SCHEMBL6764307

SCHEMBL6764307

C(#Cc1ccccc1C#CC1(C#Cc2ccccc2C#Cc2ccccc2)C2CC3CC(C2)CC1(c1ccccc1)C3)c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HSD11B1 P28845 4/20 0.35
APP P05067 1/20 0.32
CA12 O43570 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
RAB9A P51151 1/20 0.31
KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6765059 0.90 HSD11B1 (0.36) MEN1KMT2AHSD11B1APPKCNH2
SCHEMBL6765078 0.86 HSD11B1 (0.35) HSD11B1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6762051 0.82 HSD11B1 (0.33) MEN1KMT2AHSD11B1GRIN2DGRIN3B
SCHEMBL6770638 0.81 HSD11B1 (0.33) HSD11B1
SCHEMBL6762003 0.76 NPC1 (0.33) NPC1KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL6767079 0.73 HSD11B1 (0.41) KDM4EMEN1KMT2AHSD11B1GRIN2D
SCHEMBL6770724 0.72 GRIN2D (0.30) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6683930 0.69 ALDH1A1 (0.42) NPC1KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL2319389 0.69 MAPT (0.39) NPC1KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL6766893 0.68 GRIN2D (0.36) HSD11B1APPKCNH2GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040127715-A1 Adamantane compounds and insulating film forming coating solutions SUMITOMO CHEMICAL COMPANY, LIMITED 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127715-A1 Adamantane compounds and insulating film forming coating solutions CHRNA1, ANO1, CHRNA2 NPC1 696/4885KDM4E 1921/4885MEN1 521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.